Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland.
Department of Psychiatry and Psychotherapy, Christian-Albrechts-Universitat zu Kiel, Kiel, Germany.
Int J Psychiatry Clin Pract. 2019 Nov;23(4):258-264. doi: 10.1080/13651501.2019.1611863. Epub 2019 May 20.
Depression is highly prevalent worldwide and generates significant economic burden. Despite this, there is still insufficient information on hospitalisation costs related to depression. Therefore, this paper presents a comparison of costs of inpatient care of depression among patients hospitalised in 2014 in Kiel (Germany) and in Poznan (Poland). The retrospective study was conducted from October 2015 to May 2017 in Kiel and in Poznan and concerned all patients ( = 548 and eventually included = 444; 334 in Kiel and 110 in Poznan) hospitalised in these centres. The annual cost of inpatient care of patients hospitalised due to depression in 2014 was EUR [Formula: see text] = EUR 9397.21 (total EUR 313,8667.2) in Kiel and EUR [Formula: see text] = EUR 2962.90 (total EUR 325,919.38) in Poznan. In Kiel, the most frequently prescribed medicine was mirtazapine while in Poznan it was venlafaxine. The 3-fold difference in average costs of hospitalisation might result from differences in funding of mental health care which in Poland needs urgent amendment. Besides, mental health care was underfunded in Poznan. In general, treatment was comprehensive in both centres. Non-pharmacological treatment, however, was more comprehensive in Kiel.KEY POINTSThe cost of inpatient care of depression was very high both in Kiel and Poznan.Inpatient care of depression is long-lasting, but a reduction in the length of hospital stay seems to be possible.Hospital stay is the main part of costs of inpatient care of depression.Treatment of depression should be comprehensive, but differences e.g. in pharmacotherapy used are possible between hospitals and/or countries.
抑郁症在全球范围内高发，造成了巨大的经济负担。尽管如此，有关抑郁症住院费用的信息仍然不足。因此，本文比较了 2014 年在德国基尔和波兰波兹南住院的抑郁症患者的住院治疗费用。这项回顾性研究于 2015 年 10 月至 2017 年 5 月在基尔和波兹南进行，涉及这两个中心的所有患者（ = 548 人，最终纳入 = 444 人；基尔 334 人，波兹南 110 人）。2014 年因抑郁症住院的患者的住院治疗年度费用为基尔 9397.21 欧元（总计 3138667.2 欧元），波兹南 2962.90 欧元（总计 325919.38 欧元）。在基尔，最常开的药物是米氮平，而在波兹南，最常开的药物是文拉法辛。住院平均费用相差三倍可能是由于心理健康护理资金的差异造成的，波兰迫切需要对此进行修正。此外，波兹南的心理健康护理资金不足。总体而言，两个中心的治疗都很全面。然而，基尔的非药物治疗更全面。关键点基尔和波兹南的抑郁症住院治疗费用都非常高。抑郁症的住院治疗持续时间长，但似乎可以缩短住院时间。住院治疗是抑郁症住院治疗费用的主要组成部分。抑郁症的治疗应该全面，但不同医院和/或国家之间可能会存在药物治疗等方面的差异。
